Requires hospital and emergency room physicians to consult the prescription monitoring program registry and to notify a patient's prescriber that such patient is being treated for a controlled substance overdose.
Summary
Bill S07357 amends the public health law to require hospital and emergency room physicians to notify a patient's prescriber when the patient is being treated for a controlled substance overdose. This notification is intended to enhance communication between healthcare providers and ensure that prescribers are aware of their patients' overdose treatments, which could influence future prescribing practices and patient care. The bill also mandates that emergency room practitioners consult the prescription monitoring program registry when treating such patients, thereby promoting better tracking of controlled substance use.
Impact
If enacted, this bill will strengthen the existing framework around the monitoring of controlled substances in New York State. It will require healthcare providers to share critical information regarding overdose treatments, which could lead to improved patient outcomes and more informed prescribing practices. The amendments will also reinforce the use of the prescription monitoring program registry, potentially reducing the risk of prescription drug misuse and enhancing overall public health efforts related to substance abuse.
Sentiment
The sentiment surrounding Bill S07357 appears to be generally supportive, as it aims to address the critical issue of controlled substance overdoses and improve communication among healthcare providers. However, there may be concerns regarding the implementation of the notification process and the additional responsibilities placed on emergency room practitioners.
Contention
Notable points of contention may arise from healthcare providers who feel that the additional requirement to notify prescribers could complicate emergency care processes or lead to delays in treatment. Additionally, there may be concerns about the adequacy of the prescription monitoring program and whether it can effectively support the increased demand for consultations as mandated by the bill.
Permits patients to indicate that they should not be prescribed opiates and certain other controlled substances in prescription monitoring program information.
Requires prescriptions for animals to be issued in name of animal owner; prohibits unnamed persons from possessing prescribed drugs; and requires Prescription Monitoring Program to include information about controlled substances prescribed by veterinarians.
Physicians assistants; Pharmacy Act; prescriptions for controlled dangerous substances; Physician Assistant Act; Committee; members; requirements; Public Health Code; authority for physician assistants to carry out certain functions; prescribing and administering controlled substances; supervision.
Physicians assistants; Pharmacy Act; prescriptions for controlled dangerous substances; Physician Assistant Act; Committee; members; requirements; Public Health Code; authority for physician assistants to carry out certain functions; prescribing and administering controlled substances; supervision.
Requires practitioners to discuss certain risks with a patient who is being prescribed a schedule II controlled substance or an opioid analgesic; requires the department of health to develop practitioner guidelines.
Requires practitioners to discuss certain risks with a patient who is being prescribed a schedule II controlled substance or an opioid analgesic; requires the department of health to develop practitioner guidelines.
Revises sections of the uniform controlled substances act to remove specific opioid dosage requirements and revises the uniform controlled substances act in accordance with current standards of professional practice.
Revises sections of the uniform controlled substances act to remove specific opioid dosage requirements and revise the uniform controlled substances act in accordance with current standards of professional practice.
Revises sections of the uniform controlled substances act to remove specific opioid dosage requirements, revises the uniform controlled substances act in accordance with current standards of professional practice and would repeal chapter 37.4 of title 5.